Factors predicting early discontinuation of methotrexate as a first-line treatment for rheumatoid arthritis in Italy: Results from the GISEA registry
Objective: Despite the well-established efficacy of methotrexate (MTX) in rheumatoid arthritis (RA), monotherapy is not sufficient in almost half of patients. The aim of this registry-based study was to detect possible predictive factors for the early failure of MTX as a first-line treatment in earl...
Main Authors: | Andreina Manfredi, Marco Sebastiani, Florenzo Iannone, Elisa Gremese, Alessandra Bortoluzzi, Ennio Favalli, Roberto Gorla, Fausto Salaffi, Enrico Fusaro, Rosario Foti, Luca Cantarini, Roberto Caporali, Alberto Cauli, Stefano Alivernini, Francesco Paolo Cantatore, Antonio Carletto, Fabrizio Conti, Salvatore D'Angelo1, Oscar Epis, Roberta Ramonda, Antonio Marchesoni, Gianfranco Ferraccioli, Giovanni Lapadula |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Indian Journal of Rheumatology |
Subjects: | |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=4;spage=271;epage=276;aulast=Manfredi |
Similar Items
-
GISEA: an Italian biological agents registry in rheumatology
by: F. Trotta, et al.
Published: (2011-11-01) -
Effects of Anti-TNF Alpha Drugs on Disability in Patients with Rheumatoid Arthritis: Long-Term Real-Life Data from the Lorhen Registry
by: Matteo Filippini, et al.
Published: (2014-01-01) -
Biologic therapy and spinal radiographic progression in patients with axial spondyloarthritis: A structured literature review
by: Xenofon Baraliakos, et al.
Published: (2020-03-01) -
Mucocutaneous Involvement in Behçet’s Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives
by: Cinzia Rotondo, et al.
Published: (2015-01-01) -
Treatment Comparison in Rheumatoid Arthritis: Head-to-Head Trials and Innovative Study Designs
by: Ennio Giulio Favalli, et al.
Published: (2014-01-01)